[Assessment of stage IIB lung cancer from the pathological factors].
In our experience, the prognosis of patients with pathological T3N0M0 lung cancer is generally poor, the 5-year survival rate being almost the same as that of patients with stage IIIA disease. Thus, we assessed patients with stage IIB disease by examining the pathological factors, lymphatic invasion, vessel invasion, histological type, differentiation, tumor size, and node dissection. Lymphatic invasion was found to be positive in 20 of 21 cases, patients with T3N0M0 lung cancer, and all of those with positive vessel invasion had a significantly poor prognosis. This indicates that positive lymphatic and vessel invasion could be a prognostic factor predicting a poor outcome. Patients with T3N0M0 lung cancer that are found to have this poor prognostic factor may not be diagnosed as having stage IIB disease.
Tanaka
T
T
First Department of Surgery, Yamaguchi University School of Medicine, Yamaguchi, Japan.
Kaneda
Y
Y
Fujita
N
N
Ueda
K
K
Saeki
K
K
Sakano
H
H
Matsuoka
T
T
Sudo
M
M
Hayashi
M
M
Zempo
N
N
Esato
K
K
D000368:Aged; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification* / Q000401:mortality / Q000473:pathology*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging / Q000379:methods*; D011379:Prognosis; D015996:Survival Rate